Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1993
Parenteral pamidronate prevents thyroid hormone-induced bone loss in ratsH N Rosen, E K Sullivan, V L Middlebrooks, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 12, 2018
Implementing a fracture liaison service open model of care utilizing a cloud-based toolS L Greenspan, A Singer, K Vujevich, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2021
How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global surveyN R Fuggle, A Singer, C Gill, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2014
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture TrialH G Bone, D W Dempster, J A Eisman, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.The Journal of Clinical Endocrinology and Metabolism|February 26, 2000
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study GroupH G Bone, S L Greenspan, C McKeever, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2020
Factors associated with the contemplative stage of readiness to initiate osteoporosis treatmentG Adami, K G Saag, A S Mudano, et al.Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 27, 2009
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study designF H Hooven, J D Adachi, S Adami, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 9, 2012
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)C Roux, A Wyman, F H Hooven, et al.Pageof 15